Intravenous immunoglobulin as a rescue therapy for severe adult autoimmune hemolytic anemia: Results from a French multicenter observational study
- PMID: 38742870
- DOI: 10.1002/ajh.27361
Intravenous immunoglobulin as a rescue therapy for severe adult autoimmune hemolytic anemia: Results from a French multicenter observational study
References
REFERENCES
-
- Jäger U, Barcellini W, Broome CM, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the First International Consensus Meeting. Blood Rev. 2020;41:100648.
-
- Fattizzo B, Zaninoni A, Nesa F, et al. Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias: severe, refractory and fatal autoimmune hemolytic anemias. Am J Hematol. 2015;90(8):E149‐E151.
-
- Pouchelon C, Lafont C, Lafarge A, et al. Characteristics and outcome of adults with severe autoimmune hemolytic anemia admitted to the intensive care unit: results from a large French observational study. Am J Hematol. 2021;97(10):E371.
-
- Flores G, Cunningham‐Rundles C, Newland AC, Bussel JB. Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients. Am J Hematol. 1993;44(4):237‐242.
-
- Mueller‐Eckhardt C, Salama A, Mahn I, Kiefel V, Neuzner J, Graubner M. Lack of efficacy of high dose intravenous immunoglobulin in autoimmune haemolytic anaemia: a clue to its mechanism. Scand J Haematol. 2009;34(5):394‐400.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources